CMT2N-causing aminoacylation domain mutants enable Nrp1 interaction with AlaRS

Litao Sun,Na Wei,Bernhard Kuhle,David Blocquel,Scott Novick,Zaneta Matuszek,Huihao Zhou,Weiwei He,Jingjing Zhang,Thomas Weber,Rita Horvath,Philippe Latour,Tao Pan,Paul Schimmel,Patrick R. Griffin,Xiang-Lei Yang
DOI: https://doi.org/10.1073/pnas.2012898118
IF: 11.1
2021-03-22
Proceedings of the National Academy of Sciences
Abstract:Significance Charcot-Marie-Tooth disease (CMT) is a devastating motor and sensory neuropathy with an estimated 100,000 afflicted individuals in the US. Unexpectedly, aminoacyl-tRNA synthetases are the largest disease-associated protein family. A natural explanation is that the disease is associated with weak translation or mistranslation (caused by editing defects). However, our results with six different disease-causing mutants in AlaRS ruled out defects in aminoacylation or editing as causal factors. Instead, specific mutant proteins gained a neuropilin 1 (Nrp1)-AlaRS interaction. Previously a gain of Nrp1 interaction with a different disease-causing tRNA synthetase was mechanistically linked to the pathology of CMT. Thus, our results raise the possibility that pathological engagement of Nrp1 is common to at least a subset of tRNA synthetase-associated cases of CMT.
multidisciplinary sciences
What problem does this paper attempt to address?